Cisplatin ic50 breast cancer

WebJun 15, 2024 · Background: As a type of breast cancer that has relatively strong invasiveness, triple negative breast cancer (TNBC) seriously affects the survival of patients. microRNAs (miRNAs) have been shown to exert a prominent regulatory effect on the disease, among which miR-133b is reported to be involved in the pathological … WebNational Center for Biotechnology Information

Biomedicines Free Full-Text Preparation, Characterization of …

WebAbstract Cisplatin (DDP) is a common therapeutic option for non-small cell lung carcinoma (NSCLC). However, some patients fail to respond to the DDP chemotherapy. ... USP14 … WebApr 12, 2024 · Taking NVP-BEZ235 (BEZ235) as an example to screen drug response-related genes (DRRGs) and explore their potential value in triple-negative breast cancer (TNBC). Through high-throughput technique ... theralene meddispar https://catherinerosetherapies.com

Anticancer effect of curcumin on breast cancer and stem cells

WebApr 10, 2024 · Triple-negative breast cancer (TNBC) is one of the most aggressive forms of breast cancer and constitutes 10–20% of all breast cancer cases. Even though platinum-based drugs such as cisplatin and carboplatin are effective in TNBC patients, their toxicity and development of cancer drug resistance often hamper their clinical use. WebCarboplatin (NSC 241240, JM-8, CBDCA,Paraplatin) is a DNA synthesis inhibitor by binding to DNA and interfering with the cell's repair mechanism in A2780, SKOV-3, IGROV-1, and HX62 cells. Solutions are best fresh-prepared. DMSO is not recommended to dissolve platinum-based drugs, which can easily lead to drug inactivation. CAS No. … WebOn the other hand, a combination of PI3K/Akt inhibitors and cisplatin have displayed a synergistic anti-tumor effect in chemo-resistant cancer cells including those of melanoma, breast and lung ... theralen restnoterat

Biomedicines Free Full-Text Preparation, Characterization of …

Category:TGF-β-Induced TMEPAI Attenuates the Response of Triple …

Tags:Cisplatin ic50 breast cancer

Cisplatin ic50 breast cancer

Effect of miR-133b on progression and cisplatin resistance of …

WebJan 14, 2024 · Cisplatin has been widely used in the treatment of a various types of cancers including triple-negative breast cancer (TNBC) by damaging DNA and inducing apoptosis. However, its anti-cancer effects … WebApr 11, 2024 · Hypoxia is one of the major causes of cancer resistance and metastasis. Currently, it is still lack of convenient ways to simulate the in vivo hypoxic tumor microenvironment (TME) under normoxia in vitro. In this study, based on multi-polymerized alginate, we established a three-dimensional culture system with a core-shell structure …

Cisplatin ic50 breast cancer

Did you know?

WebMar 22, 2024 · The drug’s IC 50 values indicated that the cells had acquired a stable CDDP-resistance phenotype, with the IC 50 values of the A549/DDP cells remaining significantly higher than the parental A549... WebJan 10, 2024 · Cisplatin [cis-diamine platinum (II) dichloride] is widely used as a drug of choice for treating various cancers, and it is the first platinum-based drug approved by US-FDA 6, 7. The mechanism of...

WebApr 2, 2024 · IC50 values for ( a–d) bortezomib- and ( e–h) cisplatin-treated MCF7, HCC38, MCF-10A, and MDA-MB-436 breast cancer … WebIC 50 values for cisplatin, curcuminoid, and combination treatments in A549 cell culture. Standard deviation values are provided after the ± symbol for each inhibitory concentration value. Cell...

WebJun 22, 2024 · Cisplatin (DDP) was reported to improve pathological complete response (pCR) rates in triple-negative breast cancer (TNBC) patients, however, the molecular mechanism still remains largely unknown. Emerging evidence suggested that some chemotherapeutic drugs played anti-tumor effects by inducing cell pyroptosis. WebFeb 28, 2024 · All the new complexes showed cytotoxicity in vitro against the three cancer cell lines, but only complex 1a showed statistically significant different activity compared …

WebCisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner. Exosomes from DDP …

WebCisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner Exosomes from DDP-resistant TNBC cells (231/DDP) altered the sensitivity of other breast cancer cells to DDP in an exosomal miR-423-5p dependent manner. sign set crow groundedWebApr 10, 2024 · Triple-negative breast cancer (TNBC) is one of the most aggressive forms of breast cancer and constitutes 10–20% of all breast cancer cases. Even though … theralgaWebUsing MTT assay, IC50 values of cisplatin and 5‑fluorouracil were determined to be 14.2 and 8.9 µM for cisplatin and 5‑fluorouracil, respectively. The effects of different concentrations of cisplatin and 5‑fluorouracil in combination with two different concentrations of bortezomib were examined in the 4T1 cells. the raley\\u0027s way portalWebFeb 28, 2024 · All the new complexes showed cytotoxicity in vitro against the three cancer cell lines, but only complex 1a showed statistically significant different activity compared with cisplatin, with significantly lower IC 50 values, 4.31, 6.23, and 4.80 μM, compared with 9.71, 14.48, and 11.59 μM for cisplatin against A549, SKOV3, and MCF-7, respectively. signs everywhere a signsigns ewe is close to lambingWebJun 1, 2024 · The IC50 decreased by 50% under curcumin cotreatment relative to that under single drug treatment. The cisplatin IC50 of the MBA-MB-231 and MCF-7 cell lines … theralica avis cheveuxWebOn the other hand, a combination of PI3K/Akt inhibitors and cisplatin have displayed a synergistic anti-tumor effect in chemo-resistant cancer cells including those of … the raley\u0027s pantry